A phase II trial of ponatinib and blinatumomab in adults with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL).
Year: 2023
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Nicholas James Short, Elias Jabbour, Nitin Jain, Walid Macaron, Xuelin Huang, Guillermo Montalban-Bravo, Tapan M. Kadia, Naval Guastad Daver, Fadi Haddad, Marianne Zoghbi, Cedric Christophe Nasnas, Lewis Fady Nasr, Ejiroghene Mayor, Wuliamatu Deen, Jennifer Thankachan, Christopher Loiselle, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop M. Kantarjian
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4379281673